TTOO (TTOO) Stock Price & Analysis
TTOO (TTOO) rose 400.00% to USD 0 as of June 10, 2026 at 02:32 UTC, according to Nexqual real-time market data.
TTOO last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 35 shares. Market capitalization is $56,090, with a 52-week range of USD 0–0.16 (PNK). Source: Nexqual, June 10, 2026 at 02:32 UTC.
Key Statistics (as of June 10, 2026 at 02:32 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 400.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.16 |
| Volume | 35 shares |
| Market Cap | $56,090 |
| Exchange | PNK |
Technical Analysis (TTOO)
Nexqual's technical model rates TTOO "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 02:32 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.44 (neutral) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Analyst Ratings (TTOO)
Wall Street analysts rate TTOO "None", per Nexqual as of June 10, 2026 at 02:32 UTC.
| Consensus Rating | None |
|---|
Earnings (TTOO)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-06-30 | USD -0.66 vs est -0.97 ▲ beat |
| 2024-03-31 | USD -2.66 vs est -1.86 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:32 UTC.
Financials & Fundamentals (TTOO)
| Total Revenue | $7.68M |
|---|---|
| Revenue Growth (YoY) | +34.90% |
| Gross Margin | -247.83% |
| Operating Margin | -511.89% |
| Profit Margin | +0.00% |
| Current Ratio | 0.4 |
| Total Cash | $2.08M |
| Total Debt | $18.94M |
| Free Cash Flow | $-26.37M |
Source: Nexqual, June 10, 2026 at 02:32 UTC.
Financial Health Score (TTOO)
Nexqual rates TTOO's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:32 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $2M cash vs $19M debt |
| Cash Flow | Weak — Operating cash flow -$37M |
| Efficiency | Mixed — No data |
Ownership (TTOO)
| Insider Ownership | +5.38% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 28.05M |
| Float | 11.90M |
| Short % of Float | +4.87% |
Source: Nexqual, June 10, 2026 at 02:32 UTC.
Leadership (TTOO)
TTOO is led by Craig R. Jalbert CIRA (age 63), CEO, President, Corporate Treasurer, Corporate Secretary & Director, per Nexqual as of June 10, 2026 at 02:32 UTC.
| CEO, President, Corporate Treasurer, Corporate Secretary & Director | Craig R. Jalbert CIRA (age 63) |
|---|---|
| Senior Vice President of Science Research & Development | Roger Smith (age 60) |
Major Backers & Investors (TTOO)
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.55% |
Source: Nexqual, June 10, 2026 at 02:32 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TNXP | Tonix Pharmaceuticals Holding C | USD 11.46 | ▲ 3.52% |
| IBIO | iBio, Inc. | USD 1.7 | ▼ 6.59% |
| JAGX | Jaguar Health, Inc. | USD 2.82 | ▲ 0.71% |
| SENS | Senseonics Holdings, Inc. | USD 7.43 | ▲ 11.39% |
| BNGO | Bionano Genomics, Inc. | USD 1.16 | ▼ 0.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:32 UTC. This page is informational and not investment advice.